{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:49:02Z","timestamp":1794574142429,"version":"4.9.1"},"reference-count":75,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Chimeric Antigen Receptor T\u2010cell Immunotherapy represents a breakthrough in treating relapsed\/refractory hematologic malignancies, yet immune\u2010related adverse events, particularly hemophagocytic lymphohistiocytosis (HLH), also known as immune effector cell\u2010associated HLH\u2010like syndrome (IEC\u2010HS), are rapid\u2010progressing and life\u2010threatening. This systematic review and meta\u2010analysis searched PubMed, Embase, and Cochrane CENTRAL up to August 20, 2025. Nineteen studies were analyzed using a random\u2010effects model, covering 2780 patients, 47 HLH cases, and 20 HLH\u2010related deaths. The pooled incidence of HLH was 1.6% at a median follow\u2010up of 12.9\u2009months, with an associated HLH mortality of 0.7%. The incidence of HLH differed markedly by disease entity (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0008), highest in B\u2010cell acute lymphoblastic leukemia (B\u2010ALL: 6.9%). CAR T\u2010cell product was also a significant determinant (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0036), with tisagenlecleucel (Tisa\u2010cel) showing the highest incidence (4.3%). Subgroup analyses confirmed that Tisa\u2010cel had a significantly higher HLH incidence than axicabtagene ciloleucel (Axi\u2010cel) in large B\u2010cell lymphoma (2.4% vs. 0.6%,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.038), and ciltacabtagene autoleucel (Cilta\u2010cel) had a higher incidence than idecabtagene vicleucel (Ide\u2010cel) in multiple myeloma (2.6% vs. 0.7%,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.022). Higher\u2010grade cytokine release syndrome (CRS) was positively correlated with HLH incidence, particularly in MM. Overall HLH incidence was significantly positively correlated with mortality. In conclusion, HLH risk after CAR T\u2010cell therapy is primarily driven by underlying disease type and specific CAR T\u2010cell product, with additional contribution from severe CRS. Enhanced surveillance and early intervention are strongly recommended for high\u2010risk groups, particularly B\u2010ALL patients and recipients of Tisa\u2010cel or Cilta\u2010cel.\n                  <\/jats:p>","DOI":"10.1002\/ajh.70351","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T02:58:14Z","timestamp":1778036294000},"page":"1839-1855","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hemophagocytic Lymphohistiocytosis After\n                    <scp>CAR<\/scp>\n                    T\u2010Cell Therapy: A Systematic Review and Meta\u2010Analysis"],"prefix":"10.1002","volume":"101","author":[{"given":"Changhui","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Hematology, Lymphoma Research Center Peking University Third Hospital  Beijing China"},{"name":"First Clinical Medical College Gannan Medical University  Ganzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Wu","sequence":"additional","affiliation":[{"name":"First Clinical Medical College Gannan Medical University  Ganzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Cao","sequence":"additional","affiliation":[{"name":"First Clinical Medical College Gannan Medical University  Ganzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoling","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine Affiliated Hospital of Jiujiang University  Jiujiang China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjian","family":"Yan","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Fujian Medical University  Quanzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Qi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Lymphoma Research Center Peking University Third Hospital  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Lymphoma Research Center Peking University Third Hospital  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingzhao","family":"Ji","sequence":"additional","affiliation":[{"name":"First Clinical Medical College Shanxi Medical University  Taiyuan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4958-2489","authenticated-orcid":false,"given":"Hongmei","family":"Jing","sequence":"additional","affiliation":[{"name":"Department of Hematology, Lymphoma Research Center Peking University Third Hospital  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Peng","sequence":"additional","affiliation":[{"name":"First Clinical Medical College Gannan Medical University  Ganzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4052-200X","authenticated-orcid":false,"given":"Weilong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Lymphoma Research Center Peking University Third Hospital  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00642"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.281455"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2023.03.006"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2020.101515"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2024.06.012"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1914347"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyac163"},{"issue":"10","key":"e_1_2_10_9_1","first-page":"2127","article-title":"Methodological Quality of Case Series Studies: An Introduction to the JBI Critical Appraisal Tool[J]","volume":"18","author":"Munn Z.","year":"2020","journal-title":"JBI Evidence Synthesis"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)90201-Y"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/ebmental-2019-300117"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v036.i03"},{"key":"e_1_2_10_13_1","first-page":"40","article-title":"meta: An R Package for Meta\u2010Analysis[J]","volume":"7","author":"Schwarzer G.","year":"2007","journal-title":"R News"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2024.06.022"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1482"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1752"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00690"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00842"},{"issue":"19","key":"e_1_2_10_21_1","first-page":"2307","article-title":"Five\u2010Year Follow\u2010Up of ZUMA\u20101 Supports the Curative Potential of Axicabtagene Ciloleucel in Refractory Large B\u2010Cell Lymphoma","volume":"141","author":"Neelapu S. S.","year":"2023","journal-title":"Blood"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02986-9"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01052-8"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2213614"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00339-4"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709866"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.280805"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3881"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02104"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-24-01730"},{"issue":"1","key":"e_1_2_10_31_1","article-title":"Idecabtagene Vicleucel or Ciltacabtagene Autoleucel for Relapsed or Refractory Multiple Myeloma: An International Multicenter Study[J]","volume":"9","author":"Merz M.","year":"2025","journal-title":"Hema"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024025945"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01365"},{"key":"e_1_2_10_34_1","article-title":"Infectious Complications in Pediatric, Adolescent and Young Adult Patients Undergoing CD19\u2010CAR T Cell Therapy","volume":"12","author":"Maron G. M.","year":"2022","journal-title":"FrontOncol"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2021.11.019"},{"key":"e_1_2_10_36_1","first-page":"184","article-title":"Cytopenias and Infections Following Ciltacabtagene Autoleucel in Heavily\u2010Pretreated Relapsed or Refractory Multiple Myeloma[J]","author":"Dima D.","year":"2025","journal-title":"Haematologica"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.02477"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-148013"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.148"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17662"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.5209"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18454"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-02878-7"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021011898"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-021-00585-3"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29102"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.03.014"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.222471"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17331"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1158\/2643-3230.BCD-21-0203"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022008256"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.1158\/2643-3230.BCD-21-0181"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024014995"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-09-602946"},{"key":"e_1_2_10_55_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-10-3413"},{"key":"e_1_2_10_56_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022008893"},{"key":"e_1_2_10_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature09671"},{"key":"e_1_2_10_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.137"},{"key":"e_1_2_10_59_1","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-185"},{"key":"e_1_2_10_60_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-208307"},{"key":"e_1_2_10_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26668"},{"key":"e_1_2_10_62_1","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aay8248"},{"key":"e_1_2_10_63_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04372-4"},{"issue":"1","key":"e_1_2_10_64_1","first-page":"83","article-title":"Impact of the Kinetics of Circulating Anti\u2010CD19 CAR\u2010T Cells and Their Populations on the Outcome of DLBCL Patients","volume":"14","author":"Mart\u00edn\u2010Mart\u00edn L.","year":"2024","journal-title":"BloodCancer J"},{"key":"e_1_2_10_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-021-00530-z"},{"key":"e_1_2_10_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19117"},{"key":"e_1_2_10_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2022.03.013"},{"issue":"1","key":"e_1_2_10_68_1","first-page":"27","article-title":"Bispecific Antibodies and CAR\u2010T Cells: Dueling Immunotherapies for Large B\u2010Cell Lymphomas","volume":"14","author":"Trabolsi A.","year":"2024","journal-title":"BloodCancer J"},{"key":"e_1_2_10_69_1","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2025.13578"},{"issue":"11","key":"e_1_2_10_70_1","first-page":"3037","article-title":"Inhibition of Natural Killer Cell Cytotoxicity by Interleukin\u20106: Implications for the Pathogenesis of Macrophage Activation Syndrome.Arthritis","volume":"67","author":"Cifaldi L.","year":"2015","journal-title":"Rheumatologist"},{"key":"e_1_2_10_71_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2022.2081147"},{"key":"e_1_2_10_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101161"},{"key":"e_1_2_10_73_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60980-2"},{"issue":"12","key":"e_1_2_10_74_1","article-title":"Impact of Immunological Aging on T Cell\u2010Mediated Therapies in Older Adults With Multiple Myeloma and Lymphoma","volume":"12","author":"Ullrich F.","year":"2024","journal-title":"J ImmunotherCancer"},{"key":"e_1_2_10_75_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1701655"},{"key":"e_1_2_10_76_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01193-6"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.70351","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ajh.70351","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.70351","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:35:09Z","timestamp":1792762509000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.70351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":75,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1002\/ajh.70351"],"URL":"https:\/\/doi.org\/10.1002\/ajh.70351","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"2026-01-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}